Exelixis Inc. | Key People and Executives
Charles M. Cohen
Independent Director
Michael M. Morrissey
President, Chief Executive Officer & Director
Stelios B. Papadopoulos
Chairman
Maria C. Freire
Independent Director
Julie Anne Smith
Independent Director
Alan M. Garber
Independent Director
Carl B. Feldbaum
Independent Director
George A. Scangos
Independent Director
Vincent T. Marchesi
Independent Director
Lance Willsey
Independent Director
George H. Poste
Independent Director
Jack L. Wyszomierski
Independent Director
Michael M. Morrissey
President, Chief Executive Officer & Director
Christopher J. Senner
Chief Financial & Accounting Officer, Executive VP
Peter Lamb
Chief Scientific Officer & EVP-Scientific Strategy
Gisela M. Schwab
Chief Medical Officer & President-Medical Affairs
Andrew Peters
Vice President-Strategy
Stefan Krauss
Vice President-Business Development
William Berg
Senior Vice President-Medical Affairs
PJ Haley
Senior Vice President-Commercial
Gregg Bernier
Vice President-Marketing
Susan T. Hubbard
Executive VP-Public Affairs & Investor Relations
Laura Dillard
Senior Vice President-Human Resources
Jeffrey J. Hessekiel
Executive Vice President & General Counsel
Stelios B. Papadopoulos
Chairman
Maria C. Freire
Independent Director
Julie Anne Smith
Independent Director
Alan M. Garber
Independent Director
Carl B. Feldbaum
Independent Director
George A. Scangos
Independent Director
Vincent T. Marchesi
Independent Director
Lance Willsey
Independent Director
Charles M. Cohen
Independent Director
George H. Poste
Independent Director
Jack L. Wyszomierski
Independent Director
| Address |
1851 Harbor Bay
Parkway Alameda California 94502
United States
|
|
Employees
|
- |
| Website |
http://www.exelixis.com |
| Updated |
07/08/2019 |
| Exelixis, Inc. is a biopharmaceutical company, which engages in the development, commercialization, and discovery of new medicines for the treatment of cancer. It offers products under the brands of Cometriq, Cabometyx, and Cotellic. The company was founded by Corey S. |
